58) acterized for their aerodynamic diameter, specific surface area (cm(2)/g) and fine p |
59) ic diameter of 4.58 μm, FPF of 66% and specific surface area of 6302.99 cm(2)/g |
60) The specific surface area of PGMA nanobeads wa |
61) The specific surface area of the mPHEMA nanosp |
62) activity and capability due to their high specific surface areas and nanosize effect |
63) lated, counted and characterized by their specific surface marker profile 2 and 24 |
64) gely correlated with the FMD virus (FMDV)-specific antibodies. |
65) ive in a first survey in spring 2012, SBV-specific antibodies were detected in almos |
66) herds were tested for the presence of SBV-specific antibodies. |
67) though the clinical significance of donor-specific antibodies is far from being esta |
68) Here we used specific antibodies against N-acetylaspart |
69) This effect was specific for ethanol and acetaldehyde sinc |
70) europaeus agglutinin I (UEA-I), a lectin specific for human endothelium, and Griffo |
71) em, Nucleotide Diagnostic (ND) characters specific for species were identified. |
72) g-term metabolic complications, which are specific for the various bariatric procedu |
73) bodies in serum or cerebrospinal fluid is specific for this novel and widely under-d |
74) Specific phobias are among the most freque |
75) promising efficient pharmacotherapies for specific phobias consists of drugs that en |
76) be considered for patients suffering from specific phobias in case they were non-adh |
77) n of nonantidepressant pharmacotherapy of specific phobias. |
78) use of antidepressant in the treatment of specific phobias. |
79) written words is associated with category-specific brain activation in the ventral o |
80) ile tool for acquiring the input data for specific brain analyses. |
81) erning the differential susceptibility of specific brain areas to neuronal death. |
82) nd some cortical regions that are part of specific brain networks that in part are i |
83) These feature-specific effects indicate that brief train |
84) on micrographs, indicating additional non-specific effects. |
85) ical models that take account of provider-specific effects form the basis of the pro |
86) No sex-specific effects in response to ELS were o |
87) ess in tailoring culture conditions using specific growth factors and biomechanical |
88) The application of specific growth factors for osteoinduction |
89) effect of letrozole and tamoxifen on the specific growth rate (SGR; % day(-1)), gon |
90) The specific growth rates of O. |
add keyword